Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Current Assets (2016 - 2025)

Historic Current Assets for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $50.1 million.

  • Anterix's Current Assets rose 2428.19% to $50.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.1 million, marking a year-over-year increase of 2428.19%. This contributed to the annual value of $60.8 million for FY2025, which is 1678.65% down from last year.
  • As of Q4 2025, Anterix's Current Assets stood at $50.1 million, which was up 2428.19% from $58.8 million recorded in Q3 2025.
  • In the past 5 years, Anterix's Current Assets registered a high of $135.0 million during Q4 2021, and its lowest value of $40.3 million during Q4 2024.
  • In the last 5 years, Anterix's Current Assets had a median value of $69.1 million in 2022 and averaged $77.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 5542.22% in 2023, then surged by 4984.49% in 2024.
  • Anterix's Current Assets (Quarter) stood at $135.0 million in 2021, then plummeted by 46.33% to $72.5 million in 2022, then rose by 7.43% to $77.8 million in 2023, then tumbled by 48.26% to $40.3 million in 2024, then grew by 24.28% to $50.1 million in 2025.
  • Its Current Assets stands at $50.1 million for Q4 2025, versus $58.8 million for Q3 2025 and $55.4 million for Q2 2025.